As a postpartum doula, Dawn Oliver does her best work in the middle of the night. During a typical shift, she shows up at her ...

This roundtable explores how pharma can realign its strategy to ensure visibility, resonance and results in today’s shifting ...

The Trump administration’s broadsides against scientific research have caused unprecedented upheaval at the National Cancer ...

People affected by the crisis are increasingly worried that no one seems to be guarding the opioid settlement cash while elected officials eye it hungrily.

The lookout for pharma tariffs is back on. A few months after President Donald Trump announced sweeping trade tariffs, he has once again threatened to slap drug manufacturers with tariffs “very soon.” ...

Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...

RFK Jr. cancels U.S. Preventive Services Task Force meeting; the Department of Health and Human Services backtracked on its claim that it would release ethics forms for new members of the Advisory ...

MM+M today revealed its 2025 MM+M Awards finalists. Now in its 22nd year, the medical marketing industry’s premier awards program returns with a new category and expansions of existing ones. The ...

Tremfya snagged Dupixent’s place as the pharma brand with the most TV impressions in June, according to data released by iSpot.tv on Friday morning. The Johnson & Johnson brand garnered a 4.3% share ...

When an ambulance company charges more than an insurer is willing to pay, patients can be left with a big bill they probably had no choice in.

Yaccarino wrote on X that she will ‘cheer’ on the company’s remaining team as they ‘continue to change the world.’ ...